Skip to content

A Study on the Effects of Mastiha Oil in Adults With Hypertriglyceridemia

A Study on the Effects of Mastiha Oil in Adults With Hypertriglyceridemia

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06323252
Enrollment
100
Registered
2024-03-21
Start date
2024-04-01
Completion date
2025-10-30
Last updated
2024-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertriglyceridemia

Brief summary

Mastiha Oil is a 100% natural product of the Mediterranean, extracted from the resin of Mastiha. Its composition is high in bioactive ingredients (such as terpenic acids and polyphenols) which have proven anti-inflammatory, antioxidant, cardioprotective, chemoprotective and antimicrobial properties. The aim of this study is to determine the effect of Mastiha oil in adults with Hypetriglyceridemia. 100 participants will be allocated to two groups, (50 in intervention group and 50 in control group). Mastiha oil will be provided in the form of soft gel capsules to the intervention group, whereas the control group will not consume the capsules. Both groups will receive standard nutritional counselling. The intervention will last 3 months. The effects of the intervention will be evaluated via clinical and laboratory markers.

Interventions

DIETARY_SUPPLEMENTMastihaOil

1 soft gel capsule of Mastiha oil every day for 3 months

BEHAVIORALnutritional counsel

nutritional counsel

Sponsors

Harokopio University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* 30 years \< Age \< 75 years Hypetriglyceridemia A stable weight for ≥ 3 months pre-intervention An unchanged treatment regimen for ≥ 6 months pre-intervention

Exclusion criteria

Hepatotoxic Medication Untreated Diabetes Mellitus Dysthyroidism, hypopituitarism, Cushing syndrome / disease Pregnancy, lactation Psychiatric or mental disorder Any use of antioxidant-phytochemical rich supplement, vitamin D supplement, anti-, pre- or pro-biotics within 3 months pre-intervention

Design outcomes

Primary

MeasureTime frameDescription
Change in blood triglycerides3 monthsLevels will be evaluated pre and prost intervention in both control and intervention groups

Contacts

Primary ContactAndriana C Kaliora, Ass. Professor
akaliora@hua.gr+30 2109549226

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026